about
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.VAV3 mediates resistance to breast cancer endocrine therapy.Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.Biological reprogramming in acquired resistance to endocrine therapy of breast cancer.TACC3-TSC2 maintains nuclear envelope structure and controls cell division.Evaluation of PAX3 genetic variants and nevus number.Evidence for a link between TNFRSF11A and risk of breast cancer
P50
Q33721249-6C4E9AB2-2C00-4DB7-8D2B-DCB96E711795Q33827037-30543333-DE3E-4D92-829A-38B2B4074C94Q34588331-6BE3BCEC-F00D-4544-AD54-82E13E12886CQ39667297-7B61BF39-1BE0-4A84-BA2A-206398BFAD84Q43125822-E0B97EA1-993A-4A8D-A6E5-7577FC4D08A3Q45366506-1A9C17BB-8FE9-4C79-8CD3-7185AE83EB24Q57881796-DAB63F59-59E9-409A-8E09-431CED78D466
P50
description
researcher ORCID ID = 0000-0002-8193-6825
@en
wetenschapper
@nl
name
Nuria Bonifaci
@ast
Nuria Bonifaci
@en
Nuria Bonifaci
@es
Nuria Bonifaci
@nl
type
label
Nuria Bonifaci
@ast
Nuria Bonifaci
@en
Nuria Bonifaci
@es
Nuria Bonifaci
@nl
prefLabel
Nuria Bonifaci
@ast
Nuria Bonifaci
@en
Nuria Bonifaci
@es
Nuria Bonifaci
@nl
P21
P31
P496
0000-0002-8193-6825